A pioneering study uncovers crucial immune dynamics in hepatitis B, offering new insights into how immune responses evolve ...

Vir Biotechnology, Inc. progresses HDV treatment with promising ECLIPSE program results. Click here to find out why VIR stock ...

Previously used to treat HIV and Hepatitis B, nucleoside reverse transcriptase inhibitors (NRTIs) reduced the risk of ...

Let us delve into some of the TLR agonists in the clinic and why the careful selection of these drugs is crucial.

SCG Cell Therapy Pte Ltd (SCG), a clinical-stage biotechnology company pioneering TCR T cell therapy for infectious diseases and associated cancers, today announced late-breaking clinical data from ...

Hepatitis D virus (HDV) infects the liver and causes severe inflammation. According to WHO estimates, 12 million people worldwide are infected with HDV. Currently, there are only a few treatment ...

The Italian study showed that patients with HCC resulting from viral infections or fatty liver had significantly higher ...

It therefore depends on the presence of HBV, and the hepatitis B vaccination also protects ... and cannot prevent the daughter cells from also carrying the virus when infected liver cells divide.

This is DTIL’s lead, fully owned in vivo gene editing program aimed at curing chronic hepatitis ... hepatitis B virus (HBV) — and inactivating integrated HBV DNA in liver cells (hepatocytes).